Literature DB >> 32753005

Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C.

B Islas-Muñoz1, B Méndez-Sotelo1, J Reyes-Pérez2, M Jiménez-de Los Santos2, R Herrera-Goepfert3, P Volkow-Fernández1.   

Abstract

We present the case of a 28-year-old man with recently-diagnosed human immunodeficiency virus and hepatitis C virus infection. He developed obstructive cholangiopathy secondary to cytomegalovirus and Kaposi sarcoma, both diagnosed by endoscopic retrograde cholangiopancreatography and biopsies. He received antiretroviral therapy, chemotherapy and valganciclovir with full recovery.

Entities:  

Keywords:  AIDS; Cholangiopathy; Kaposi sarcoma; cytomegalovirus

Mesh:

Substances:

Year:  2020        PMID: 32753005     DOI: 10.1177/0956462420943027

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  1 in total

1.  Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients.

Authors:  Julio Flores-Gonzalez; Lucero A Ramon-Luing; Ranferi Ocaña-Guzman; Ivette Buendia-Roldan; Beda Islas-Muñoz; Patricia Volkow-Fernández; Leslie Chavez-Galan
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.